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Developing kidneyMdm2 (Murine Double Minute-2) is required to control cellular p53 activity and protein levels. Mdm2 null
embryos die of p53-mediated growth arrest and apoptosis at the peri-implantation stage. Thus, the absolute
requirement for Mdm2 in organogenesis is unknown. This study examined the role of Mdm2 in kidney
development, an organ which develops via epithelial–mesenchymal interactions and branching morpho-
genesis. Mdm2 mRNA and protein are expressed in the ureteric bud (UB) epithelium and metanephric
mesenchyme (MM) lineages. We report here the results of conditional deletion of Mdm2 from the UB
epithelium. UBmdm2−/− mice die soon after birth and uniformly display severe renal hypodysplasia due to
defective UB branching and underdeveloped nephrogenic zone. Ex vivo cultured UBmdm2−/− explants
exhibit arrested development of the UB and its branches and consequently develop few nephron progenitors.
UBmdm2−/− cells have reduced proliferation rate and enhanced apoptosis. Although markedly reduced in
number, the UB tips of UBmdm2−/−metanephroi continue to express c-ret and Wnt11; however, there was a
notable reduction in Wnt9b, Lhx-1 and Pax-2 expression levels. We further show that the UBmdm2−/− mutant
phenotype is mediated by aberrant p53 activity because it is rescued by UB-speciﬁc deletion of the p53 gene.
These results demonstrate a critical and cell autonomous role for Mdm2 in the UB lineage. Mdm2-mediated
inhibition of p53 activity is a prerequisite for renal organogenesis.L-37, Tulane University School
2, USA. Fax: +1 504 988 1771.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Congenital abnormalities of the kidney and urinary tract account
for 30–40% of end-stage renal disease in infants and children (Bates,
2000; Cain et al., 2010). The etiology of a majority of them arises from
defects in the ﬁne balance between proliferation, survival, differen-
tiation and the acquisition of physiological function. The deﬁnitive
kidney or metanephros develops through reciprocal signaling
between the ureteric bud (UB), an epithelial outgrowth of the
Wolfﬁan or mesonephric duct, and the metanephric mesenchyme
(MM) (Costantini and Kopan, 2010; Lechner and Dressler, 1997).
These proximate interactions result in reiterative branching of the UB
leading to the formation of an elaborate collecting duct system.
Meanwhile the MM assumes one of three fates, namely, epithelial
renal vesicles (which will ultimately form the mature nephrons),
stroma, or vascular elements (Dressler, 2009). Disruptions, either
genetic or chemical, of the reciprocal signaling pathways result in
impaired growth and/or differentiation of the component tissues
leading to agenesis or dysgenesis of the kidney (Cain et al., 2010).
Tightly coordinated cell death and survival decisions have a direct
impact on embryonic development and in adult tissue homeostasis.Deregulation of these processes results in pathological conditions.
Owing to the growth inhibitory and apoptosis-promoting functions of
the tumor suppressor p53, there are strict mechanisms in place to
regulate p53 levels and activity under normal physiological conditions
(Harris and Levine, 2005; Oren et al., 2002; Poyurovsky and Prives,
2006). Mdm2 is recognized as a potent negative regulator of p53
stability and function (Lozano and Montes de Oca Luna, 1998; Wade
et al., 2010).Mdm2 was originally identiﬁed as an ampliﬁed gene on
double-minute chromosomes in transformed mouse ﬁbroblasts
(Fakharzadeh et al., 1991). Subsequently, it was found to interact with
p53 and to inhibit its function through twomain mechanisms: ﬁrst, the
direct binding of Mdm2 to the N-terminal domain of p53 inhibits the
transcriptional activation function of p53 (Momand et al., 1992; Oliner
et al., 1993); second, Mdm2 possesses E3 ubiquitin activity that targets
p53 for degradation through the 26S proteasome (Haupt et al., 1997;
Kubbutat et al., 1997). The vital interaction betweenMdm2andp53was
clearly revealed by elegant genetic studies which showed that the peri-
implantation lethality of Mdm2 null mice can be circumvented by the
concomitant deletion of p53 (Jones et al., 1995; Montes de Oca Luna
et al., 1995). Remarkably,Mdm2 itself is in turn a transcriptional target of
p53 and together they form an autoregulatory feedback loop (Barak
et al., 1993; Perry et al., 1993). In contrast, the closely related partner,
Mdm4, is not transcriptionally regulated by p53 (Marine et al., 2007).
The Mdm2–p53 signaling network has been implicated in the
development and/or homeostasis of several cell lineages. Genetic
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sufﬁcient for Mdm2 demonstrate that the Mdm2–p53 signaling
network supports the timely proliferation, differentiation, and
survival of several cell lineages namely hematopoietic, lymphopoietic,
cardiomyocyte, osteoblast, hepatocyte, neural, and intestinal cells
(Francoz et al., 2006; Grier et al., 2006; Lengner et al., 2006; Mendrysa
et al., 2003; Terzian et al., 2007; Xiong et al., 2007). Notably, most (but
not all) phenotypes associated with either a partial or total loss of
Mdm2 from selected tissues are efﬁciently rescued by the concom-
itant deletion of p53 or a reduction in p53dosage. In certain tissues
(e.g., heart), other members of the Mdm2 family, such asMdm4, exert
redundant developmental functions with Mdm2. With regard to the
kidney, there is suggestive evidence that Mdm2 or Mdm4 gene
function is necessary for normal kidney development. Mdm2+/−;
Mdm4+/− double heterozygous mice that survived to postnatal day
(P) 20 have small kidneys with very few glomeruli in addition to
marked hypoplasia and/or atrophy of the thymus and spleen (Terzian
et al., 2007). Using transgenic mice that express wild type p53 within
the ureteric bud, Godley et al. (1996) demonstrated the need to titrate
the expression levels of p53 for kidney development to proceed
normally. These transgenic mice exhibit acute kidney degeneration at
E17.5 reaching half the size of normal kidneys with fewer glomeruli
that are hypertrophic and ﬁbrotic. Excessive p53 interferes with the
differentiation of the ureteric buds and secondarily causes apoptosis
in the adjacent metanephric mesenchyme and its limited conversion
to epithelium (Godley et al., 1996). Given that Mdm2 is a potent
negative regulator of p53, by extrapolation it may be inferred that
Mdm2 could have a signiﬁcant role in embryonic kidney morpho-
genesis. Here, we have characterized the spatial and temporal
expression of Mdm2 in the developing kidney in mice. Utilizing a
conditional approach, we examined the consequences of Mdm2 loss
exclusively from the UB lineage on metanephric development. We
demonstrate that Mdm2 has an essential role in maintaining normal
branching morphogenesis and/or survival of the UB epithelium.
Strikingly, the loss ofMdm2 appears to disruptWnt9b, Lhx-1 and Pax2
signaling, essential for the reciprocal induction of metanephric
mesenchyme and the organization of epithelial progenitors of renal
vesicles. Genetic rescue experiments suggest that the renal pheno-
types encountered were largely p53-dependent.
Materials and methods
Animals
All animal protocols utilized were in strict adherence to guidelines
established by the Institutional Animal Care and Use Committee. For
timed pregnancies, noon of the day on which the vaginal plug was
detected was regarded as embryonic day (E) 0.5. The Mdm-2ﬂox mice
(01XH9, Dr. Mary Ellen Perry) were obtained from the NCI mouse
repository (Frederick, MD)while the R26R-EYFP reportermice (006148,
Dr. Frank Constantini) were purchased from the Jackson Laboratory
(Maine, USA). The speciﬁcations for genotyping were furnished by the
respective companies. The Hoxb7–Egfp–Cre mice (Zhao et al., 2004)
were a kind gift from Dr. Carlton Bates. The breeding strategy used
involved crossingHoxb7–Egfp–Cre;mdm2ﬂox/+ transgenicmice to either
mdm2ﬂox/ﬂox or R26REYFP/+;mdm2ﬂox/+mice. For our rescue experiments
we used both conventional and conditional approaches: accordinglywe
bred(1)Hoxb7–Cre+;p53+/−;mdm2ﬂox/+mice toHoxb7–Cre−;p53+/−;
mdm2ﬂox/+ mice or (2) Hoxb7–Cre+; p53ﬂox/+; mdm2ﬂox/+mice to
Hoxb7–Cre−; p53ﬂox/+;mdm2ﬂox/+ mice.
Reverse transcriptase-PCR
RNA was isolated from the kidneys using the Trizol reagent
(Invitrogen) according to the manufacturer's protocol. The RNA was
reverse transcribed using Random Hexamers and a ﬁrst-strandsynthesis kit (SuperScript II; Invitrogen) according themanufacturer's
recommendations. The forward and reverse primers for Mdm2 had
the following sequence: 5′ ATG TGC AAT ACC AAC ATC TCT GTG TC 3′
and 5′ GCT GAC TTA CAG CCA CTA AAT TTC 3′ respectively and yielded
a 337 bp PCR product. The PCR product corresponded to nucleotides
202–538 of the mouse Mdm2 sequence deposited under GenBank
Accession number X58876. The cycling parameters used were 94 °C
for 2 min; 30 cycles of 94 °C for 30 s, 56 °C for 30 s, 72 °C for 1 min and
a ﬁnal extension at 72 °C for 10 min.
Quantitative reverse transcriptase–PCR
Quantitative reverse transcriptase–PCRwas performed on total RNA
isolated from embryonic kidneys using the RNeasy Mini Kit (Qiagen).
Real-time primer-probemixes forMdm2 (IDMm00487652-g1Mdm2),
p53 (ID Mm01731287_m1), and Gapdh (Mm99999915-g1) were
ordered from Applied Biosystems. The Taqman expression assay was
constituted using reagents from the Brilliant II QRT–PCR 1-step Master
mix kit (Cat #600809, Agilent Technologies). The thermal proﬁle used
was as follows: 50 °C for 30 min, 95 °C for 10 min and 45 cycles of 95 °C
for 15 s, 56 °C for 1 min and 72 °C for 30 s. The reactions were done in
triplicate. The scale bars represent the standard error of mean.
Gross morphology
All bright ﬁeld images were captured on a Nikon SMZ1000
stereomicroscope mounted with a DS-Fi 1 camera with the aid of
NIS-Elements F2.20 software.
Histological staining
Periodic acid-Schiff staining (PAS)
PAS staining on parafﬁn tissue sections was done using the
Periodic Acid-Schiff Stain Kit (Richard-Allan Scientiﬁc). Brieﬂy,
deparafﬁnized and rehydrated sections were incubated in Periodic
acid solution for 5 min and Schiff Reagent for 15 min. Hematoxylin 1
was used to stain the nuclei and Bluing Reagent to intensify the color.
The slides were ﬁnally dehydrated in graded alcohol series, cleared in
Xylene and mounted using Permount mounting media.
Hematoxylin and Eosin staining
Routine histological staining using H and E involved incubation in
Hematoxylin 2 for 2 min and Eosin Y (Richard-Allan Scientiﬁc) for
1 min.
Organ culture
Ex vivo kidney explants were grown in 6-well transwell plates with
0.4 μm pore size ﬁlters (Corning Inc). E12.5 kidneys were cultured in
Advanced DMEM/F-12 medium (Invitrogen) supplemented with 10%
fetal calf serum and 1% penicillin streptomycin at the air and medium
interface in 5% C02 atmosphere at 37 °C. To study branching morpho-
genesis the kidney explantswere cultured for 48 h and images captured
using an Olympus BX51 ﬂuorescence microscope.
Immunohistochemistry
The kidneys were ﬁxed in 10% buffered formalin and processed for
parafﬁn embedding. Four micrometer parafﬁn sections were sub-
jected to antigen retrieval (10 mM sodium citrate, pH 6.0) after
deparafﬁnization and rehydration steps. Primary antibodies used
were polyclonal rabbit anti-Mdm2 at 1:100 dilution (ab15471-1
Abcam), Dolichos biﬂorus lectin (1:40 dilution, Sigma) and rabbit anti-
Pax2 at 1:100 dilution (Zymed), Fluorescein Lotus Tetragonolobus
lectin at 1:100 dilution (FL-1321, Vector Laboratories, Inc.), polyclonal
goat anti-AQP2 at 1:500 dilution(sc-9882, Santa cruz), rabbit anti-
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rabbit phosphor-histone H3 (Ser 10) antibody at 1:100 dilution (9701,
Cell Signaling), monoclonal mouse anti-pan cytokeratin at 1:100
dilution (Sigma), polyclonal rabbit anti-WT1 (C-19:sc-192, Santa
Cruz) at 1:200 dilution, monoclonal mouse anti-E-cadherin (1:100
dilution; 610181, BD Biosciences), polyclonal rabbit anti-K-cadherin
(1:100 dilution; cadherin-6, gift from G. Dressler), polyclonal rabbit
anti-Six2 (1:200 dilution; 11562-1-AP, Proteintech), and DAPI (1:500
dilution D1306, Invitrogen). The peroxidase based Vectastain ABC
elite kit (Vector Laboratories, Inc) was used for DAB detection. For
immunoﬂuorescence detection we used donkey anti-mouse or
donkey anti-rabbit secondary IgG antibodies with Alexaﬂuor 555 or
488 conjugates (Invitrogen). The immunoﬂuorescent images were
captured using a 3D or deconvolution scope (Leica DMRXA2).Fig. 1. Expression ofMdm2 andp53 during kidney development in the mouse. (A) Semi-quan
extracted from kidneys of representative embryonic (E) stages, newborn (NB), postnatal (P)
and L) transcripts during early metanephrogenesis. Panels C and D represent the sense contro
mesonephric tubules and in the developing metanephros at E11.5 (Panels E, F). Examination
p53 andMdm2 transcripts (Panels E-L). (M, N) Immunostaining of Mdm2 in E14.5 kidney. Th
Mdm2-positive.UB: ureteric bud; SB: S-shaped body; nd: nephric duct.TUNEL assay
Recombinant Terminal Deoxynucleotidyl transferase (rTdT) me-
diated nick-end labeling (TUNEL) was performed using the Dead End
Fluorometric Tunel System (Promega) according to the manufac-
turer's guidelines. Four micrometer parafﬁn sections were ﬁxed in
methanol-free paraformaldehyde before and after proteinase K
treatment at 20 μg/ml for 8–10 min at room temperature. The sections
were incubated with the nucleotide mixture (which included
ﬂuorescein-tagged dUTP) and rTdT enzyme for an hour at 37 °C. The
slides were mounted using Vectasheild with DAPI (Vector Laborato-
ries, Inc). The images were captured using a deconvolution ﬂuores-
cent scope. Quantitative analysis of apoptotic foci to area ratio was
determined using Slidebook 4.1 (Digital Microscopy Software).titative and (B) real-time quantitative RT-PCR of p53 and Mdm2mRNA. Total RNA was
and adult mice. Spatial distribution ofMdm2 (Panels E, G, I, and K) and p53 (Panels F, H, J,
ls forMdm2 and p53 at E11.5.Mdm2 and p53 transcripts are present in the nephric duct,
of themetanephros from E11.5–13.5 revealed that both the UB andMM are enriched for
e ureteric bud lineage, the precursors of the nephron, the glomeruli, and the stroma are
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The protocol used was established in the De Robertis laboratory
and can be accessed under mouse protocols (http://www.hhmi.ucla.
edu/derobertis). The non-radioactive RNA probes carried a digox-
igenin label which was detected using anti-digoxigenin Fab fragments
coupled to alkaline phosphatase (Roche Diagnostics). BM purple was
used as the chromogenic substrate for Alkaline Phosphatase. The
Mdm2 probe was generated by in vitro transcription from a pCMV-
SPORT6 expression vector carrying full lengthMdm2 corresponding to
Accession no BC092270 (Clone ID4018419 Mouse MGC Veriﬁed FL
cDNA; Open Biosystems). We linearized and reverse transcribed with
EcoRV/T7 for antisense probe and HindIII/SP6 for sense probe. The
probe length was approximately 1.4 kb. Other probes used in our
assays were Pax2, Lhx1, cRet, Wnt11, Wnt9b, and p53.Results
Spatio-temporal expression of Mdm2 and p53 in the developing kidney
Initial studies of Mdm2 in the mouse reported low level ubiquitous
expression throughout the embryo and in the adult tissues analyzed
(Montes de Oca Luna et al., 1995). Here, we examined Mdm2 and p53
gene expression inmouse embryonic (E) and postnatal (P) kidneys. RT-
PCR (Fig. 1A) and real-time quantitative PCR (Fig. 1B) showed that
expressionof bothgenes follows a similar temporalproﬁle, beinghigh in
the embryonic kidney followed by a gradual decline in gene expressionFig. 2. Ureteric bud-speciﬁc deletion of Mdm2results in bilaterally small, hypodysplastic k
homozygous null mutant (B) littermates. Note; the contralateral adrenal gland in Panel B w
severe structural anomalies in UBmdm2−/−mice. The mutant kidneys have poor tissue organiz
cortical and medullary zones are not identiﬁable. C, D, F, and G represent Hematoxylin and E
renal vesicle; PT: proximal tubule, NZ: nephrogenic zone.postnatally. In situ hybridization revealed that Mdm2 and p53 mRNAs
are expressed in the epithelial and mesenchymal compartments of the
developingkidney (Figs. 1C–L). FromE11.5 to E13.5, both transcripts are
expressed in the Wolfﬁan duct, the mesonephric tubules, the UB, and
theMM. Immunostaining of E14.5 kidney sections revealedwidespread
expressionofMdm2 in theUBepithelium, thenephron progenitors, and
the cortical and medullary stroma (Figs. 1M, N). This spatio-temporal
expression pattern suggests a signiﬁcant role for the Mdm2–p53
pathway during nephrogenesis.Deletion of Mdm2 from the UB lineage disrupts metanephric
development
To determine ifMdm2 is required for branching morphogenesis in
the developing metanephros, we crossed mice harboring Mdm2
ﬂoxed alleles (Mdm2F/F) (Mendrysa et al., 2003) (Suppl. Fig. 1A) to
aHoxb7–Cre transgenic line that drives Crerecombinase expression
speciﬁcally in the UB lineage (Zhao et al., 2004). The progeny are
hereafter designated as wild type (UBmdm2+/+), heterozygous null
(UBmdm2+/−) or homozygous null (UBmdm2−/−). To conﬁrm the
speciﬁcity of Cre recombinase activity in our system, we crossed
Mdm2F/+;Hoxb7–Cretg/+micewithR26REYFP+/;Mdm2F/+mice. The EYFP
reporter gene is transcriptionally silent until Cre-mediated recombina-
tion removes the ﬂoxed stop cassette upstream from its coding
sequence. At E11.5, we ﬁnd EYFP reporter expression in the nephric
duct, the mesonephric tubules, and the UB. Conversely, the R26REYFP/+;
Mdm2F/+ littermate but without the Hoxb7–Cre transgene does notidneys. Gross morphology of P1 kidneys isolated from wild type (A) and conditional
as lost during dissection. (C–H) Histological staining of kidney sections at P1 reveals
ation and numerous dilated tubules resembling cysts occupy the bulk of the kidney. The
osin staining while E and H represent Periodic acid Schiff staining. Ub: ureteric bud; RV:
358 S. Hilliard et al. / Developmental Biology 353 (2011) 354–366show EYFP expression (Suppl. Fig. 1B). In situ hybridization at E13.5
conﬁrmed a marked reduction of Mdm2 transcripts in UBmdm2−/−
kidneys (Suppl. Fig. 1C).
At P1, UBmdm2−/− kidneys were remarkably smaller and hypodys-
plastic compared to those of UBmdm2+/− and UBmdm2+/+ littermate
controls (Figs. 2A, B). Histological analysis of the control and null
mutant kidney sections at P1 showed the presence of numerouscyst-
like dilated tubulesthat occupied the bulk of the null mutant kidney.
Notably, UBmdm2−/− kidneys lacked normal histo-architecture with no
demarcation of cortical and medullary zones (Figs. 2C–H).
Analyses of P1 kidney sections by immunohistochemistry was
undertaken to reveal the tissue compartments most affected by the
elimination of Mdm2. There were only a few Dolichos biﬂorus lectin-
staining collecting ducts in the UBmdm2−/− kidney sections relative to
the control (Suppl. Figs. 2A, B). This was indicative of severely
impaired branching morphogenesis of the UB. In these mutants, UB
branches failed to extend to the periphery of the kidney. Antibodies toFig. 3. Loss ofMdm2 results in an early impairment of UB branching morphogenesis. Wild ty
UB branching was visualized by EYFP ﬂuorescence. The UBbifurcates only a couple of times b
to bifurcate (Panels H, I). Kidneys from control and UBmdm2−/− littermates collected at E12.
reveal the extent of UB branching. The UB makes it to the T-stage in the UBmdm2−/− kidneyPax-2 revealed that the nephron progenitors were ill developed in
conjunction to the poorly developed UB lineage (Suppl. Figs. 2C, D).
Clearly, the nephrogenic zone, which houses actively proliferating UB
tips, nephron progenitors, and cortical stroma, was poorly developed
in the mutant UBmdm2−/− kidneys. As expected, proximal tubulogen-
esis (LTA-positive tubules) was less affected than UB branching
(Suppl. Figs. 2E, F). In contrast, AQP-2 water channel, a marker of the
principal cells of the collecting ducts, was expressed in few collecting
ducts (Suppl. Figs. 2G–J). Therefore, renal development was compro-
mised in mutant UBmdm2−/− secondary to UB growth and branching
defects.
Requirement for Mdm2 in early UB branching morphogenesis
Having established thatMdm2 is necessary for kidney development,
we wanted to determine the developmental stage at which the defect
becomes ﬁrst evident. In the conditional UBmdm2−/− mutant kidneys,pe (A–C) and UBmdm2−/− (D–I) explants were harvested at E12.5 and cultured for 48 h;
efore it arrests (Panels E, F), and in some cases, the UB invades the mesenchyme but fails
5 (Panels J and K) and E14.5 (Panels L and M) and stained with anti-pan cytokeratin to
s but arrests shortly thereafter.
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in controls, although the ﬁrst branching pattern appears dysmorphic
and occasionally fails to occur altogether (see subsequent discussion).
We followed branching morphogenesis of E12.5 UBmdm2−/− and
littermate control kidney explants ex vivo. During 24–48 h in culture,
the explants of UBmdm2−/− growvery poorly and theUB either branches
once or twice or fails to branch as compared to the wild type UB which
undergoes remarkable growth and branching (Figs. 3A–I). The
divergence in branching pattern was most apparent at E12.5 with a
signiﬁcant drop in the number of UB tips and branch points and
consequently visibly smaller kidneys during later organogenesis.
Branching of theUBappears to arrest following theﬁrst two generations
of branching, although elongation remains less affected (Figs. 3J–M).
Immunostaining of sections from E14.5 and E15.5 explants with
antibodies to Pax2 (a marker of epithelial nephron progenitors) and
cytokeratin (a marker of the UB branches) revealed a marked
diminution of UB branches and tips (Figs. 4A–D, A′, B′; G, H, G′, H′;
the cap mesenchyme (CM) is present but highly disorganized in
UBmdm2−/− as compared to wild type kidneys (Figs. 4E, F). By E15.5,
wild type UB branches have elongated and reached the periphery of
the cortex; in contrast, few if any UBmdm2−/− stalks or tips areFig. 4. Effect ofMdm2gene deletion in the UB lineage on nephron progenitors. E14.5 and E15
H, and J) kidney sections were co-stained with antibodies to Pax2 and cytokeratin. Note tha
nephron progenitors such as renal vesicles (RV; compare G, I vs. H, J). The cap mesenchymobserved in the nephrogenic zone (Figs. 4G, H). The loss of UBs was
accompanied by a secondary reduction in nascent nephrons (e.g. renal
vesicles, RV) (Figs. 4I, J). A more extensive analysis of the progenitor
cell population at E14.5 using Six2 antibodies conﬁrms that Six2+ CM
cells are present in the dysplastic UBmdm2−/− kidneys and surround
the remnant UB branches; however, the cap mesenchyme is clearly
disorganized (Figs. 5A–F and Suppl. Fig. 3). As a result, fewer nephrons
are formed in UBmdm2−/− kidneys. This is illustrated by the paucity of
WT1+ glomeruli in mutant as compared to wild type kidneys
(Figs. 5G–L and Suppl. Fig. 3).
Loss of Mdm2 from the UB induces apoptosis and growth arrest
In order to understand the cellular mechanism(s) leading to
impaired UB branching in the UBmdm2−/−mutants, we assayed for cell
apoptosis and cell proliferation. We used the TUNEL assay to examine
cell apoptosis at E14.5. Given that the mutant kidneys were
signiﬁcantly smaller in size relative to the controls we considered
the number of apoptotic foci to area ratio. The UB epithelium was
labeled by antibodies to cytokeratin. Subsequent to the loss of Mdm2
from the UB, we ﬁnd that apoptosis is induced in the UB branches of.5 littermate control, UBmdm2+/+ (Panels A, C, E, G, and I) and UBmdm2−/− (Panels B, D, F,
t UBmdm2−/− kidneys are smaller, contain fewer UBs (compare A′ vs. B′; G′ vs. H′) and
e (CM) appears intact but disorganized (compare E vs. F).
Fig. 5. Effect of Mdm2 gene deletion in the UB lineage on Six2+ progenitors cells andWT1+ cells. E14.5 kidneys sections from UBmdm2+/+and UBmdm2−/− littermates were immuno-
stained for Six2 and E-cadherin (Panels A–F) or WT1 and cytokeratin (Panels G–L). In both wild type and mutant embryonic kidneys, Six2+ progenitor cells are located in the cap
mesenchyme (compare C vs. F). However, the Six2+ population in UBmdm2−/− appears less condensed and at times forming a thicker cap around the poorly developed UB tip
regions. Defective nephrogenesis is reﬂected by fewer WT1+ podocyte progenitors and capillary loop glomeruli (g) (compare H and K). UB: ureteric bud; CM: cap mesenchyme.
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found in the ureter of UBmdm2−/− kidney (Figs. 6E–H). At E16.5, we
observed widespread and extensive apoptosis in both the UB and MM
(data not shown). Quantitative analysis demonstrated that the rate
of apoptosis is approximately 3.0-fold higher in the UBmdm2−/−
than control kidneys (Fig. 6I). Immunostaining with anti-cleaved
caspase-3 antibodies, another indicator of apoptosis, conﬁrmed
marked apoptosis in the UB branches and ureter ofUBmdm2−/− kidneys
(Figs. 7A–T). Notably, the cleaved caspase-3 staining in the condi-
tional mutants has an unusual sub-cellular localization, being largely
restricted to the apical borders of the UB cells. In all probability, this
marks a very early apoptotic event in these cells since the nuclear
morphology/density in the activated caspase-3 staining cell popula-
tion is normal. These cleaved caspase-3 positive bodies could be
related to mitochondria or some kind of early apoptotic vesicles. In
conjunction with caspase-mediated apoptosis, the UBmdm2−/−
kidneys also showed fewer phospho-histone3 staining foci per area
relative to those of littermate controls (Figs. 8A–F). Quantitative
analysis conﬁrmed that reduced cell proliferation occurs in the
homozygous UBmdm2−/− but not in heterozygous littermates
(Fig. 8G). Thus, decreased cell viability and cell proliferation could
explain the hypoplastic kidneys in the mutant mice.
Deletion of p53 from the UB lineage rescues renal development in
UBmdm2−/− mice
Mdm2 elimination leads to unchecked p53 activity with lethal
consequences (de Rozieres et al., 2000). In these instances, theconcomitant loss of p53 was enough to restore viability. Therefore,
we asked if Mdm2 regulation of p53 is vital to UB branching
morphogenesis and nephrogenesis. To this end, we used a genetic
rescue approach that involved crossing Hoxb7–Cretg/+; Mdm2F/F
mice to p53−/− mice (Jacks et al., 1994) or p53F/F mice (Saifudeen
et al., 2009). The results revealed that deletion of one p53 allele on
UBmdm2−/− background (UBmdm2−/−; p53+/−) was not sufﬁcient to
mount a full rescue of the renal phenotype. Signiﬁcantly, elimination of
both p53 alleles from the whole kidney anlagen (UBmdm2−/−; p53−/−)
or speciﬁcally from the UB lineage (UBmdm2−/−; p53−/−) rescues
postnatal survival (Tables 1 and 2). The kidney size and histo-
architecture of the rescued mice at birth are comparable to those of
control wild typemice from the same litter (Figs. 9A–C′). Moreover, the
rescued embryos exhibit normal branching of the UB (Figs. 9D–I).
Ureteric bud speciﬁc loss of Mdm2 disrupts gene expression
To examine the impact ofMdm2 deletion on some of themolecular
mediators of UB branching morphogenesis, we analyzed their
expression in the null mutants by in situ hybridization. At E11.5, c-
Ret, a receptor tyrosine kinase for GDNF, is expressed in the WD, UB
and its branches (Fig. 10A). The expression of c-Retwas maintained in
the UBmdm2−/− mutants although the ﬁrst branching usually resulted
in mis-shaped T (Fig. 10B). Notably, Wnt9b is suppressed in the WD
and UB at E11.5 (Figs. 10C, D). Release of Wnt9b from the UB initiates
the nephrogenesis program by activating β-catenin signaling and
mesenchyme-to-epithelium transition. At E12.5, downregulation of
Wnt9b in the UB branches of UBmdm2−/− becamemore evident but this
Fig. 6. Conditional elimination ofMdm2 leads to extensive apoptosis in the ureteric bud
lineage. Cytokeratin Immunostaining (A, B, E, F) and TUNEL assay (C, D, G, H) on
consecutive sections ofE14.5 control and mutant UBMdm2−/−kidney showing excessive
apoptosisin the mutant ureteric epithelium. (I) Quantitative analysis of the number of
apoptotic foci per ﬁeld area. There is a 3-fold elevation in the levels of apoptosis in the
UBMdm2−/− compared to wild type and heterozygous mutant kidneys.
361S. Hilliard et al. / Developmental Biology 353 (2011) 354–366may simply reﬂect reduced cell numbers at this point (Figs. 11A, B).
The reduced number of UB tips in the UBmdm2−/− correlated with
fewer Wnt11 expressing-UB tips at E12.5 (Figs. 11C, D). Notably,
Lhx1and Pax2were markedly decreased reﬂecting reduced number of
induced nascent nephrons in UBmdm2−/− (Figs. 11E–H). By E13.5,
there were very few UB tips in the mutants that stained positively for
c-Ret compared to littermate controls (Figs. 12A, B). Expression of
Wnt9b in the UB stalks was markedly downregulated in the E13.5
UBmdm2−/− kidney (Figs. 12C, D). Expression of the transcription
factors, Lhx1 and Pax2, in the UB tree and progenitors was also
signiﬁcantly reduced in UBmdm2−/− kidneys (Figs. 12E–H). Together,
the early transcriptional effects onWnt9b and subsequent alterations
in transcription factors Lhx1 and Pax2 likely contribute to impaired
growth and development of mutant UBmdm2−/− kidneys.
Discussion
The present study demonstrates that kidney-speciﬁc inactivation
of Mdm2 results in renal hypodysplasia that is mediated by p53-
mediated growth arrest and apoptosis. Thus, tight regulation of p53
by Mdm2 is absolutely required to sustain branching morphogenesis
in the developing kidney.
Control of p53 activity by Mdm2 is indispensible for embryogen-
esis and organogenesis to progress normally. Pursuant to the loss of
Mdm2 there is an increase in the levels and/or activity of p53
compromising viability of the embryo (Chavez-Reyes et al., 2003; de
Rozieres et al., 2000; Montes de Oca Luna et al., 1995). Our studyextends these global embryonic functions of Mdm2 demonstrating an
absolute requirement for Mdm2 in mammalian renal organogenesis.
This conclusion is based on the following evidence. The temporal and
spatial expression of p53 and its transcriptional target, Mdm2, in the
UB and surrounding MM is consistent with a role of the Mdm2-p53
pathway in nephrogenesis. UB-speciﬁc elimination ofMdm2 results in
bilaterally small hypodysplastic kidneys with few collecting ducts and
isolated glomeruli. Consequently, UBmdm2−/− mice die shortly after
birth and do not survive to weaning. An early arrest of UB branching
morphogenesisis detected both in vivo and in ex vivo cultures of
UBmdm2−/− kidneys associated with extensive apoptosis in the UB
epithelium and reduced cell proliferation. Furthermore, targeted
inactivation of Mdm2 in the UB results in downregulation of key
developmental regulators, e.g., Wnt9b at E11.5 and Lhx1 and Pax2 at
E12.5–13.5. When the loss ofMdm2 in the UB was combined with the
loss of p53 either in the UB lineage or in the germline, we observed a
complete rescue of the renal phenotype, which in turn allowed the
survival of the compound mutant mice to adulthood. Interestingly,
even 50% gene dosage of p53 proved detrimental to proper UB
morphogenesis in the absence of functional Mdm2. Thus, the tight
regulation of p53 function by Mdm2 is a prerequisite for mammalian
nephrogenesis.
The reiterative pattern by which the UB epithelia arborize is
governed by factors that promote its proliferation and migration and
those that repress ectopic budding and improper branching (Bush et
al., 2006; Costantini, 2006; Costantini and Kopan, 2010). Our study
demonstrates that Mdm2 regulation of p53 stability/activity is
necessary to sustain branching morphogenesis and to ensure proper
patterning as it dichotomizes during nephrogenesis. The importance
of the Mdm2–p53 nexus to renal organogenesis is underscored by the
complete rescue of branching morphogenesis, kidney size, and cyto-
architecture upon concomitant p53 loss in our genetic models.
Although the present study was not designed to investigate the
precise signaling pathways (downstream of p53) which negatively
affected renal development in the absence of Mdm2, it is likely that
the molecular pathogenesis of the renal defect is complex and
multifactorial considering the pleiotropic role of p53 in cellular
homeostasis. For example, it was reported that the PI3K/PTEN node is
essential for the proper patterning of the dichotomizing UB in
responseto GDNF-cRet signaling (Kim and Dressler, 2007). According
to this model, PTEN antagonizes PI3K function allowing the
accumulation of inositol triphosphates only at the leading edge of
the growing UB epithelium. This allows directed cell migration in
response to GDNF in the metanephric mesenchyme. Akt and Mdm2
are downstream effectors of the PI3K pathway that ensure cell
survival, growth, proliferation and migration (Mayo and Donner,
2002). On the other hand, PTEN is a transcriptional target of p53 and a
mediator of p53-triggered apoptosis (Stambolic et al., 2001). It is
tempting to speculate that the targeted inactivation of Mdm2 in the
UB lineage might be altering the ﬁne balance exerted by the PI3K/
PTEN node essentially compromising branching morphogenesis.
Mdm2 can be envisioned as forming the hub through which
multiple mitogenic signals are coordinated. During embryogenesis,
HGF–Met signaling through PI3K–Akt–mTOR triggers Mdm2 upregu-
lation which ensures survival of the hepatocytes (Moumen et al.,
2007). Ishibe et al. (2009) demonstrated that mice with genetic
disruption of Met and Egfr signaling in the UB cells show a marked
decrease in UB branching leading to small kidneys, renal failure and
lethality. This phenotype is reminiscent of UBmdm2−/− mice.
The constitutive regulation of p53 by Mdm2 is essential for organ
development and tissue homeostasis to proceed normally. Thus, a
third mechanism by which loss or downregulation of Mdm2 affects
kidney development is via unchecked p53-mediated apoptosis or cell
cycle arrest, as demonstrated in studies of other organs, such as the
lymphocytes, osteoblasts, neuronal progenitors/postmitotic neurons,
cardiomyocytes, smooth muscle cells of the GI tract, and epithelial
Fig. 7. Activation of caspase-3 mediated apoptosis in UBMdm2−/− kidneys. Double Immunostaining for cytokeratin (green) and activated caspase-3 (red) in sections of E14.5 control
(Panels A, C–J, S) and mutant UBMdm2−/− (Panels B, K-R, T) kidneys demonstrates that the effector of apoptosis, caspase 3, is induced in mutant UBMdm2−/− cells. Nuclei are
counterstained with DAPI (blue).
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Lengner et al., 2006; Mendrysa et al., 2003; Xiong et al., 2006). As is
the case with our study, rescue of themutant phenotypewas achieved
only by the complete elimination of p53. Our attempts to show
accumulation of the p53 protein in UBmdm2−/− kidneys werehampered by the lack of reliable p53 antibodies that recognize
mouse p53 on tissue sections. Regardless, the complete rescue of the
renal Mdm2-null phenotype by germline or lineage-speciﬁc p53
deletion provides a direct genetic proof that the observed phenotype
is p53-mediated.
Fig. 8. Reduced cell proliferation accompanies the poor growth of the mutantUBMdm2−/−
kidneys. Double immunoﬂuorescence for cytokeratin (green) and p-H3 (red) in E14.5
kidney sections of wild type (Panels A–C) and mutant (D–F) kidneys. Nuclei are
counterstained with DAPI (blue). (G) A bar graph depicting quantitatively the reduced
levels of cell proliferation in the conditional nullmutant kidneys compared to thewild type
and conditional heterozygous kidneys.
Table 2
Survival to adulthood following concomitant deletion of Mdm2 and p53.
Age Mdm2F/+ Mdm2F/F Cre
Mdm2F/+
Cre
Mdm2F/F
P21 1 1 0 0
P0–P3 4 4 2 6
E14.5–17.5 7 9 10 9
E11.5–13.5 20 21 20 24
363S. Hilliard et al. / Developmental Biology 353 (2011) 354–366A hypomorphic mousemodel of Mdm2 shows that Mdm2 function
extends beyond its housekeeping roles to encompass developmental
processes and organogenesis (Mendrysa et al., 2003). These studies
established that constitutive regulation of p53 by Mdm2 wasTable 1
A. All genotypes expected at 25%. B. Percent of progeny with various genotypes.
A
(Hoxb7 Cretg/+; Mdm2F/+)×Mdm2F/F
Adult
n=37
Mdm2 +/+ Mdm2 F/+ Mdm2 F
p53+/+ 0 (1:32) 4 (1:16) 1 (1:32)
p53+/− 2 (1:16) 4 (1:8) 3 (1:16)
p53−/− 0 (1:32) 3 (1:16) 4 (1:32)
B
(Hoxb7 Cretg/+; Mdm2F/+)×ROSAEYFP/+; Mdm2F/+
Expected frequency 12.2% 25% 12.5%
Age Mdm +/+ Mdm2 F/+ Mdm2 F/F
P21 0 2 3
P0–P3 0 0 1
E14.5–17.5 6 18 5
E11.5–13.5 16 23 9necessary in homeostatic tissues of postnatal mice. Signiﬁcantly,
these mice presented with reduced body weight, lymphopenia and
with severe defects in hematopoiesis, all phenotypes being p53
dependent (Mendrysa et al., 2003). Lengner et al. (2006) followed the
effects of complete loss of Mdm2 on bone growth and differentiation
during embryogenesis and in adult tissues. They found that
conditional elimination of Mdm2 in the osteogenic lineage resulted
in multiple skeletal defects as a result of heightened p53 activity.
Notably, in the absence of Mdm2-mediated regulation of p53, the
induction of Runx2, the master regulator of osteoblast differentiation
is greatly reduced in the osteoblast progenitors. As a result, there is
excessive apoptosis early on in the caudal somites followed by
reduced proliferation and maturation of osteoblasts at a later stage.
Godley et al. (1996) reported that mice expressing a wild type p53
transgene succumbed to end-stage renal disease. These mice
presented with smaller kidneys having half the number of nephrons
and glomerulosclerosis by E18.5. Although, from the rescue experi-
ment it is safe to conclude that the phenotype we see is the
consequence of p53 over expression, our observations differ from
those of Godley et al. (1996) in a number of aspects. Firstly, the
UBmdm2−/− kidneys were phenotypically recognizable as early as
E13.5 as opposed to E18.5 with p53 transgenic kidneys. Secondly, we
observed severe impairment of UB branching morphogenesis in the
UBmdm2−/− kidneys while branching defects were not reported in
p53-transgenic mice. Thirdly, p53-transgenic mice manifested pat-
terning defects such as ectopic expression of cRet, and absence of DB
lectin and AQP-2 in the collecting ducts at E18.5. Albeit fewer in
number, we still observe DB lectin-positive collecting ducts that are
more centrally located, having failed to extend to the periphery. Also,
AQP-2 protein is present in the UBs of UBmdm2−/− mice. Finally, the
p53 transgenic kidneys did not show any alteration of WT1 or LTA
staining. In contrast, we observed reduced WT1 staining in newborn
UBmdm2−/− with severe depletion of renal progenitors. The presence
of functional Mdm2 in the kidneys expressing transgenic p53 could/F Cre
Mdm2 +/+
Cre
Mdm2 F/+
Cre
Mdm2 F/F
0 (1:32) 2 (1:16) 0 (1:32)
3 (1:16) 5 (1:8) 0 (1:16)
0 (1:32) 3 (1:16) 3 (1:32)
12.5% 25% 12.5%
Cre
Mdm2 +/+
Cre
Mdm2 F/+
Cre
Mdm2 F/F
n
0 3 0 8
1 1 0 3
4 11 4 48
13 32 12 105
Fig. 9. Genetic rescue of kidney development in UBMdm2−/−mice by germline or UB-speciﬁc p53 deletion. Complete rescue of kidney size and histo-architecture in mice conditionally
null for bothMdm2 and p53 in the UB. Urogenital blocks from newborn wild type mice (Panel A), UBmdm2−/− (Panel B), and UBmdm2−/−;p53−/− (Panel C). Corresponding histology of
the P0 kidneys shown in A, B, and C (Panels A′, B′ and C′ respectively). Note the rescue of nephrogenic elements in the outer cortex. Deletion of both p53 alleles (in this case in the
germline) restores UB growth and branching to that of wild type levels. Antibodies to pan-cytokeratin stain the branching UB (green, Panels D–H), while anti-WT1 stains the
condensing mesenchyme and glomeruli (red, Panels E–I).
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onset phenotype. The ﬁndings in the current study serve to emphasize
the strict requirement for Mdm2 in the regulation of p53 during
metanephrogenesis.
We found that Mdm2 loss in the UB compartment resulted in the
downregulation of Wnt9b in the UB and Lhx1 and Pax2 in nascent
nephrons. The Wnt–β-catenin pathway is required for UB branching
morphogenesis (Bridgewater et al., 2008; Marose et al., 2008) as well
as for mesenchyme-to-epithelium conversion (Carroll et al., 2005). In
a sequential step, Lhx1 mediates further differentiation of nephron
progenitors to epithelial nephrons (Kobayashi et al., 2005). The
transcriptional regulator, Pax2, is required formultiple steps of kidney
development, including UB morphogenesis and growth and survival
and differentiation of the renal progenitors (Brophy et al., 2001;
Rothenpieler and Dressler, 1993; Torres et al., 1995). Chromatinimmunoprecipitation studies coupled with next generation DNA
sequencing (ChIP-Seq) using chromatin isolated from E15.5 mouse
kidneys identiﬁed p53 binding peaks in the 5′-regulatory regions
Pax2, Lhx1, and Wnt9b genes (Saifudeen Z., and El-Dahr SS,
unpublished observations). These ﬁndings suggest that p53 target
genes include important developmental renal regulators and point to
a potential mechanism whereby dysregulation of p53 activity
contributes to the observed phenotype.
The endowment of nephrons is determined primarily by the
extent of UB branching during metanephrogenesis (al-Awqati and
Goldberg, 1998; Basson et al., 2006; Nigam and Shah, 2009; Reidy and
Rosenblum, 2009). Suboptimal nephron numbers could increase the
risk of hypertension and predispose the affected individuals to renal
insults later in life (Brenner et al., 1988; Keller et al., 2003; Poladia
et al., 2006; Woods, 1999). Although mutations in the MDM2 gene or
Fig. 10. In situ hybridization of selected developmental UB regulators at E11.5. (A,B) c-Ret,
a tyrosine kinase receptor for GDNF, is expressed in theWolfﬁanduct (WD),UBand itsﬁrst
bifurcation (T-stage) and is unaltered in the mutant UBmdm2−/−. Note the abnormal
pattern of the T bifurcation in UBmdm2−/−. (C,D) Wnt9b is normally expressed in the WD
and UB and its branches.Wnt9b expression is decreased in the UBmdm2−/−WD and UB.
365S. Hilliard et al. / Developmental Biology 353 (2011) 354–366other components of the p53–Mdm2 pathway have not been reported
in human renal dysgenesis, polymorphisms in the MDM2 gene
promoter, recently reported to modulate cancer susceptibility in
humans (Bond et al., 2004), cannot be ruled out. Future studies shouldFig. 11. In situ hybridization of selected developmental renal regulators at E12.5.
(A,B) Wnt9b expression is markedly decreased in the UB tree of mutant UBMdm2−/−
kidneys. (C,D) Expression of Wnt11, a downstream target of Ret signaling in the UB
tip cellswhichmediates UB branching, is mostly unaffected in the UBmdm2−/− kidneys.
(E,F) Lhx1, a transcription factor that is involved in multiple steps of renal
development, including differentiation of nephron progenitors, is downregulated in
the WD and to a lesser extent in the renal vesicles of the mutant UBmdm2−/− kidneys.
(G,H) Pax2 transcription factor, expressed in both UB and MM lineages, is
downregulated at E12.5 in UBmdm2−/− kidneys.
Fig. 12. In situ hybridization of developmental regulators at E13.5. (A,B) c-Ret, the
receptor for GDNF, is expressed in the few remaining UB tips of the mutant UBmdm2−/−
kidney. (C,D) Wnt9b expression is markedly reduced in UBmdm2−/− kidney. (E,F) Lhx1,
which marks nephron progenitors, is expressed in fewer nephrons and at lower levels
in UBmdm2−/− kidney. (G,H) Pax2 is downregulated in the UB and condensing
mesenchyme of UBmdm2−/− kidneys.focus on elucidating the role of Mdm2 in other compartments of the
developing kidney (e.g., the metanephric mesenchyme and stroma)
and on exploring the signaling pathways that are disrupted by loss of
Mdm2-mediated inhibition of p53 during renal organogenesis.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.03.017.
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